Aristotelis Nastos

Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

Portigon AG engages in the management of its own assets. It also provides financial services and conducts banking activities. The company was founded in 1969 and is headquartered in Duesseldorf, Germany.

TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management.

Taconic Biosciences GmbH provides research in genetics and functional genomics. It specializes in the generation of genetic models for biomedical research and testing. The company was founded on October 5, 2001 and is headquartered in Leverkusen, Germany.

NRW.BANK operates as a state-owned development bank, assisting the German Federal State of North Rhine-Westphalia in its economic and social advancements. It offers interest-subsidized loans, subordinated loans, grants, financing, and advisory services. Its business activities are strictly limited to the Federal State of North Rhine-Westphalia. It serves small and medium-sized enterprises (SMEs)/start ups, municipalities and the social housing sectors. The company was founded on August 1, 2002 and is headquartered in Duesseldorf, Germany.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

Earlybird Venture Capital GmbH & Co. KG (Earlybird VC) is an independent venture capital firm founded by Hendrik Brandis, Roland Manger, Rolf Mathies, and Christian Nagel in 1997. It is a wholly-owned subsidiary of Earlybird VC Management GmbH & Co. KG. The firm is headquartered in Munich, Germany, with another German office in Berlin, and international office in Istanbul, Turkey.

U3 Pharma AG researches and develops novel targeted therapeutics aimed at treating human disease. It develops products for hyperproliferative diseases such as cancer and commercializes human monoclonal antibody therapies directed against validated proprietary drug targets selected from its portfolio. In addition, it has created a second generation functional genomics platform, TASC, which mimics the progression of a tumor cell as it progresses towards its fully malignant cancerous state. Founded in 2001, the company is headquartered in Martinsried, Germany.

Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany.

Scienion AG develops and provides DNA biochips and protein microarrays. It provides its customers in the pharmaceutical, biotech, diagnostic and reagent supply markets, as well as in academic research institutions with products, and services to facilitate confidence and efficiency in aspects of its applications. The company was founded by Holger Eickhoff in 2000 and is headquartered in Dortmund, Germany.

Innolume GmbH manufactures laser diodes. Its products include single mode and broad-are laser diodes, DFB and DBR lasers, superluminescent diodes, semiconductor optical amplifiers, tapered amplifiers, gain chips, laser diode driver, and optical isolators. The company was founded by Bernd Meyer in 2005 and is headquartered in Dortmund, Germany.

Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany.

Ambu Innovation GmbH engages in the development and distribution of single-use and light-weight robotically-assisted high definition endoscopy products in the field of gastroenterology and gastro-intestinal surgery. Its products include invendoscope SC210, invendo ScopeController, and invendo SPU E210. The company was founded in 1992 and is headquartered in Kissing, Germany.

Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA.

Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France.

FIEGE Logistik (Schweiz) AG provides transportation and logistics services. The company is headquartered in Munchenstein, Switzerland.

BioNet Pharma GmbH engages in development of medical devices, pharmaceutical drugs and regenerative medical products. Its pipeline covers pre-clinical and clinical development programs in osteoarthritis, inflammatory joint disease, cartilage injury, and severe gingival inflammation. The company is headquartered in Martinsried, Germany.

Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts.

AyoxxA Living Health Technologies Pte Ltd. engages in the research and development on biotechnology, life, and medical science. The company was founded by Andreas Schmidt in 2010 and is headquartered in Singapore.

Chundsell Medicals AB develops and markets novel molecular diagnostics for the treatment of cancer. Its product measures the expression pattern of selected embryonic stem cell genes in prostate cancer core needle biopsies. The company was founded by Sunne Rosell and Chunde Li in 2007 and is headquartered in Solna, Sweden.

Rigontec GmbH provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The firm develops a compound stimulating the immune receptor retinoic acid-inducible gene. The company was founded by Annegret de Baey-Diepolder, Gunther Hartmann, Anna Schwickart, Marcel Renn, Christine Schuberth-Wagner and Veit Hornung in 2014 and is headquartered in Munich, Germany.

BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands.

TACALYX GmbH engages in the discovery and development of Tumor Associated Carbohydrate Antigenantibodies to treat cancer. The company was founded by Peter Sondermann, Peter H. Seeberger, and Oren Moscovitz and is headquartered in Berlin, Germany.

Synendos Therapeutics AG develops molecules for the treatment of anxiety and stress-related disorders. The company was founded by Andrea Chicca, Simon Russell and Jürg Gertsch in April 2019 and is headquartered in Allschwil, Switzerland.

Cellbox Solutions GmbH provides innovative logistics solutions for the healthcare industry to transport sensitive biological material and therapeutics that suffer from freezing during shipment but require optimal physiological conditions when transported. The company is based in Cologne, Germany. The German company's portable CO2 incubator, Cellbox, provides a controlled and optimal environment for the transport of living cells, organoids, tissues, and other sensitive biological material. Temperature and CO2 levels can be adjusted to ensure optimal incubation conditions. The company was founded in 2017 by Kathrin Adlkofer. Wolfgang Kintzel has been the CEO of the company since 2020.